MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,283,887 | +84.8% | 29,484 | +53.4% | 0.00% | – |
| Q2 2023 | $694,869 | -2.9% | 19,222 | -0.1% | 0.00% | – |
| Q1 2023 | $715,741 | -97.0% | 19,238 | -96.4% | 0.00% | -100.0% |
| Q4 2022 | $23,910,634 | -52.9% | 527,709 | -63.7% | 0.02% | -55.3% |
| Q3 2022 | $50,763,713 | +3.3% | 1,452,216 | +98.5% | 0.04% | +11.8% |
| Q2 2022 | $49,128,000 | -36.6% | 731,757 | -22.3% | 0.03% | -8.1% |
| Q1 2022 | $77,428,000 | -40.6% | 941,703 | +6.0% | 0.04% | -31.5% |
| Q4 2021 | $130,273,000 | -26.2% | 888,068 | -11.0% | 0.05% | -29.9% |
| Q3 2021 | $176,557,000 | +2.2% | 998,001 | -6.7% | 0.08% | +4.1% |
| Q2 2021 | $172,832,000 | -12.7% | 1,069,967 | -7.5% | 0.07% | -17.8% |
| Q1 2021 | $198,049,000 | -21.8% | 1,156,163 | +0.3% | 0.09% | -23.7% |
| Q4 2020 | $253,151,000 | -18.9% | 1,152,569 | -38.7% | 0.12% | -27.6% |
| Q3 2020 | $311,970,000 | +7.1% | 1,878,780 | -26.3% | 0.16% | 0.0% |
| Q2 2020 | $291,176,000 | +61.3% | 2,550,374 | +8.6% | 0.16% | +31.5% |
| Q1 2020 | $180,560,000 | -28.4% | 2,348,901 | +20.0% | 0.12% | -3.9% |
| Q4 2019 | $252,280,000 | +60.9% | 1,957,784 | -2.7% | 0.13% | +51.8% |
| Q3 2019 | $156,765,000 | -9.3% | 2,012,135 | +19.9% | 0.08% | -9.6% |
| Q2 2019 | $172,787,000 | +15.9% | 1,677,539 | -17.6% | 0.09% | +13.3% |
| Q1 2019 | $149,147,000 | +225.9% | 2,034,744 | +88.6% | 0.08% | +186.2% |
| Q4 2018 | $45,759,000 | -5.3% | 1,078,722 | +5.2% | 0.03% | +11.5% |
| Q3 2018 | $48,314,000 | +48.0% | 1,025,767 | +54.9% | 0.03% | +36.8% |
| Q2 2018 | $32,639,000 | – | 662,039 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |